Macter expands Cobolmin range with sublingual option

MG News | December 22, 2025 at 03:55 PM GMT+05:00

0:00

December 22, 2025 (MLN): Macter International Limited (PSX: MACTER) introduced Cobolmin SL, a sublingual formulation of Mecobalamin.

The company stated that Cobolmin SL offers rapid absorption and enhanced convenience for patients through sublingual administration, the company’s filing on PSX revealed today.

The product expands the existing Cobolmin range, which includes tablets and injections, and underscores Macter International’s focus on innovation in healthcare.

At the time of writing, MACTER shares were trading at Rs 337.59, up 2.51 points, or 0.75%.

Copyright Mettis Link News

Related News

PSX Closing Bell: Bulls Finish Strong

ACPL delivers strong 9MFY26 profit growth

Bank Alfalah Limited share count to double after Rs10 to Rs5 Split

Name	Price/Vol	%Chg/NChg
KSE100	167,191.38 452.22M	1.01% 1673.87
ALLSHR	99,572.56 854.13M	1.14% 1123.80
KSE30	50,589.37 258.13M	0.84% 420.31
KMI30	242,439.68 214.57M	0.52% 1247.28
KMIALLSHR	65,152.10 464.27M	0.90% 579.98
BKTi	45,989.68 77.65M	1.01% 460.44
OGTi	34,428.33 15.83M	0.36% 122.21

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	72,985.00	73,555.00 71,570.00	695.00 0.96%
BRENT CRUDE	96.62	98.26 94.93	0.70 0.73%
RICHARDS BAY COAL MONTHLY	105.00	0.00 0.00	0.10 0.10%
ROTTERDAM COAL MONTHLY	104.00	105.70 104.00	-2.70 -2.53%
USD RBD PALM OLEIN	1,175.00	1,175.00 1,175.00	0.00 0.00%
CRUDE OIL - WTI	98.36	100.42 97.00	0.49 0.50%
SUGAR #11 WORLD	13.76	14.06 13.71	-0.16 -1.15%